USSIA, GIAN PAOLO
 Distribuzione geografica
Continente #
AS - Asia 16.186
NA - Nord America 8.597
EU - Europa 3.504
SA - Sud America 1.685
AF - Africa 158
Continente sconosciuto - Info sul continente non disponibili 124
OC - Oceania 88
Totale 30.342
Nazione #
SG - Singapore 10.040
US - Stati Uniti d'America 8.276
CN - Cina 2.386
HK - Hong Kong 2.057
IT - Italia 1.601
BR - Brasile 1.276
VN - Vietnam 708
GB - Regno Unito 516
FR - Francia 445
BD - Bangladesh 326
DE - Germania 294
IN - India 177
AR - Argentina 172
CA - Canada 153
NL - Olanda 130
ID - Indonesia 105
MX - Messico 87
AU - Australia 82
EE - Estonia 80
EC - Ecuador 65
CZ - Repubblica Ceca 57
ZA - Sudafrica 56
TR - Turchia 51
IQ - Iraq 49
JP - Giappone 49
FI - Finlandia 47
PK - Pakistan 45
CO - Colombia 43
RU - Federazione Russa 43
UA - Ucraina 40
CL - Cile 38
ES - Italia 38
MD - Moldavia 26
PL - Polonia 26
PY - Paraguay 26
MA - Marocco 25
PH - Filippine 23
VE - Venezuela 22
AT - Austria 18
TN - Tunisia 18
JM - Giamaica 16
LT - Lituania 16
PE - Perù 16
SA - Arabia Saudita 16
SE - Svezia 16
IR - Iran 15
MY - Malesia 15
UZ - Uzbekistan 14
UY - Uruguay 13
BE - Belgio 12
BO - Bolivia 12
AE - Emirati Arabi Uniti 11
AL - Albania 11
BG - Bulgaria 11
CH - Svizzera 10
EG - Egitto 10
IL - Israele 10
RO - Romania 10
DO - Repubblica Dominicana 9
KE - Kenya 9
TH - Thailandia 9
TT - Trinidad e Tobago 9
AZ - Azerbaigian 8
DZ - Algeria 8
GT - Guatemala 8
HU - Ungheria 8
CR - Costa Rica 7
HN - Honduras 7
JO - Giordania 7
KW - Kuwait 7
KZ - Kazakistan 7
ET - Etiopia 6
TW - Taiwan 6
BA - Bosnia-Erzegovina 5
IE - Irlanda 5
NI - Nicaragua 5
NP - Nepal 5
NZ - Nuova Zelanda 5
SV - El Salvador 5
BY - Bielorussia 4
GR - Grecia 4
KR - Corea 4
LK - Sri Lanka 4
LV - Lettonia 4
NO - Norvegia 4
SI - Slovenia 4
XK - ???statistics.table.value.countryCode.XK??? 4
AM - Armenia 3
BH - Bahrain 3
CU - Cuba 3
LB - Libano 3
LU - Lussemburgo 3
MK - Macedonia 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
ZM - Zambia 3
BB - Barbados 2
BS - Bahamas 2
BZ - Belize 2
CY - Cipro 2
Totale 30.162
Città #
San Jose 2.438
Hong Kong 2.036
Ashburn 1.785
Singapore 1.524
Rome 1.128
Hefei 884
Council Bluffs 576
Boardman 531
Dallas 519
Columbus 468
Lauterbourg 395
London 394
Beijing 387
Shanghai 305
Ho Chi Minh City 261
Los Angeles 141
Santa Clara 134
Hanoi 133
New York 127
São Paulo 104
Amsterdam 91
San Francisco 84
Munich 70
West Jordan 61
Frankfurt am Main 53
Toronto 53
Pune 50
Tallinn 49
Rio de Janeiro 48
Seattle 48
Haiphong 46
Milan 46
Tokyo 43
Curitiba 42
Brno 40
Mexico City 40
Washington 40
Chicago 38
Montreal 35
Brooklyn 33
Guayaquil 29
Las Vegas 29
Buffalo 27
Brasília 26
Belo Horizonte 25
Turku 25
Da Nang 23
Hangzhou 22
Orem 22
Perth 22
Helsinki 21
Melbourne 20
Nuremberg 20
Santiago 20
Manchester 19
Porto Alegre 19
Atlanta 18
Biên Hòa 18
Boston 18
Johannesburg 18
Jakarta 17
Warsaw 17
Xi'an 17
Chennai 16
Quito 16
Sydney 16
Baghdad 15
Bologna 14
Buenos Aires 14
Olomouc 14
Shenzhen 14
Thái Bình 14
Canberra 13
Naples 13
Salvador 13
Stockholm 13
Surat 13
The Dalles 13
Bengaluru 12
Goiânia 12
Hanover 12
Jinan 12
Lahore 12
Ninh Bình 12
Tashkent 12
Can Tho 11
Dhaka 11
Karachi 11
Manaus 11
Montevideo 11
Ribeirão Preto 11
Staten Island 11
Tunis 11
Asunción 10
Bogotá 10
Cape Town 10
Casablanca 10
Charlotte 10
Guangzhou 10
Hyderabad 10
Totale 16.225
Nome #
Circadian variations of platelet reactivity on clopidogrel in patients treated with elective percutaneous coronary intervention 447
Leptin as predictor of cardiovascular events and high platelet reactivity in patients undergoing percutaneous coronary intervention 275
[Percutaneous repair of mitral regurgitation: a new tool in the armamentarium for advanced heart failure?] 271
Valve-in-valve technique fixes leaks after TAVI 259
Current management and prognosis of patients with recurrent myocardial infarction 250
1-year results of the subclavian access for tavi with the corevalve bioprosthesis in 132 consecutive patients 248
HEART VALVE STUDY GROUP CATHQUEST 2011 246
Contrast-induced Acute Kidney Injury in Diabetic Patients and SGLT-2 Inhibitors: A Preventive Opportunity or Promoting Element? 244
Takotsubo Syndrome and Coronary Artery Disease: Which Came First-The Chicken or the Egg? 244
3D transesophageal echocardiographic assessment of acute reverse remodeling of the tricuspid annulus after transcatheter edge-to-edge repair 240
Antithrombotic treatment in patients with atrial fibrillation undergoing coronary angioplasty: rational convincement and supporting evidence 240
[Multidisciplinary position paper on the management of patent foramen ovale in the presence of cryptogenic cerebral ischemia - Italian version 2013]. 239
A NOVEL APPROACH TO DEFINE RISK OF STENT THROMBOSIS AFTER PERCUTANEOUS CORONARY INTERVENTION WITH DRUG ELUTING STENTS: THE DERIVATION SCORE 239
Designing the Optimal Procedure: Role of CT Scan in the Planning of Transcatheter Structural Heart Interventions 237
Valve-in-Valve’ Technique Effective in Treating CoreValve Leaks 237
A case series of treatment of coronary trifurcation with a new technique: " the modified double crush technique" 235
Coronary Chronic Total Occlusion Revascularization: When, Who and How? 234
HEART VALVE STUDY GROUP CATHQUEST 12 APRIL 2013 https://www.cathquest.com 232
Prediction of type 4a myocardial infarction with the angiography-derived hemodynamic (ADDED) index 228
30 days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: a multicenter study 228
LIVE CASE TRANSCATHETER MITRAL VALVE TREATMENT FROM FERRAROTTO HOSPITAL CATANIA ITALY TO VALVE SUMMIT SANTA TECLA (CT) 30 APRIL 2010 227
Emerging from the Darkness. Sudden Cardiac Death in Cardiac Amyloidosis 226
Current Applications and New Perspectives in Optical Coherence Tomography (OCT) Coronary Atherosclerotic Plaque Assessment: From PCI Optimization to Pharmacological Treatment Guidance 226
Carcinoid Pulmonary Valve Stenosis: Multimodality Imaging and Transcatheter Valve Implant With Prestenting Technique 221
Platelet reactivity and clinical outcomes following percutaneous coronary intervention in complex higher-risk patients 220
Association Between Platelet Reactivity and Long-Term Bleeding Complications After Percutaneous Coronary Intervention According to Diabetes Status 216
Antithrombotic treatment for valve prostheses: Which drug, which dose, and when? 215
Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A Contemporary Reappraisal 213
Acute pharmacological tests in patients with primary and precapillary secondary pulmonary hypertension 212
Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data 208
Cardiovascular and metabolic effects of hyperbilirubinemia in a cohort of Italian Olympic athletes 205
Andamento dei livelli plasmatici dei neurormoni dopo il trapianto cardiaco 202
Relationship Between the Completeness of Revascularization and Myocardial Injury in Patients Treated With Percutaneous Coronary Intervention 194
Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease 176
Percutaneous Left Atrial Appendage Closure: Acute Effects on Left Atrial Pressure in Humans 173
Intracardiac echocardiography with ultrasound probe placed in the upper left pulmonary vein to guide left atrial appendage closure: First description 166
A novel tricuspid flow optimiser for severe tricuspid regurgitation (TRiFlO) 150
Integrating platelet reactivity in the age, creatinine and ejection fraction score to predict clinical outcomes following percutaneous coronary intervention in patients with chronic coronary syndrome: the PR-ACEF score 148
Impact of burden and distribution of aortic valve calcification on the hemodynamic performance and procedural outcomes of a self-expanding, intra-annular transcatheter aortic valve system 148
Advances in Transcatheter Aortic Valve Therapy in Bicuspid Aortic Valve Disease: Insight into Patient Selection, Management, and Future Directions 148
Beyond the Calcium Score: What Additional Information from a CT Scan Can Assist in Cardiovascular Risk Assessment? 147
2-YEAR RESULTS OF COREVALVE IMPLANTATION THROUGH THE SUBCLAVIAN ACCESS: A PROPENSITY-MATCHED COMPARISON WITH THE FEMORAL ACCESS 145
Long Stent Implantation on the Left Anterior Descending Coronary Artery at a Follow-Up of More Than Five Years 143
ACCURACY OF INTRACARDIAC ECHOCARDIOGRAPHY FOR AORTIC ROOT ASSESSMENT IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE IMPLANTATION 139
Arrhythmias after COVID-19 Vaccination: Have We Left All Stones Unturned? 137
expert roundtable » Present and Future Challenges in Transcatheter Aortic Valve Replacement 137
Impact of endothelial dysfunction on long-term clinical outcomes in patients with chronic coronary syndromes treated with second generation drug-eluting stent implantation 132
Non-INvasive Functional and Anatomic vascular evaluation for the prediction of coronary artery disease: The NINFA study 131
Combined procedure of transcatheter aortic valve replacement and coronary intravascular lithotripsy 127
TAVR LIVE CASE WITH COREVALVE AT 16TH ANNUAL SYMPOSIUM OF LIVE SYMPOSIUM OF COMPLEX CORONARY, VALVULAR AND VASCULAR CASES, NEW YORK, NEW YORK, USA 14TH JUNE 2013 126
3-year outcomes of self-expanding Corevalve prosthesis - The Italian Registry 123
Impact of oral anticoagulant regimens on occurrence of contrast-induced nephropathy in patients undergoing coronary angioplasty 123
"Finding the biomarker" for transcatheter mitral valve repair. Eur J Heart Fail. 2019 120
Prediction of 5-Year Mortality in Patients with Chronic Coronary Syndrome Treated with Elective Percutaneous Coronary Intervention: Role of the ACEF Score 117
Fractional Flow Reserve-Guided Coronary Revascularization: Evidence from Randomized and Non-Randomized Studies 116
ACQUIRED PULMONARY VEIN OBSTRUCTION AFTER OPEN HEART SURGERY 116
Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention 116
Invasive Assessment of Coronary Microvascular Function 111
ALTRE INDICAZIONI 110
The Spectrum of Coronary Artery Disease in Elite Endurance Athletes-A Long-Standing Debate: State-of-the-Art Review 109
Analisi dei tests farmacologici acuti nei pazienti con ipertensione arteriosa polmonare precapillare 109
QUALITY-OF-LIFE IN ELDERLY PATIENTS ONE YEAR AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION FOR SEVERE AORTIC STENOSIS 108
Impact of Mediterranean diet on metabolic and inflammatory status of patients with polyvascular atherosclerotic disease 103
ACCURACY OF INTRACARDIAC ECHOCARDIOGRAPHY FOR AORTIC ROOT ASSESSMENT IN PATIENTS CANDIDATED TO TRANSCATHETER AORTIC VALVE IMPLANTATION 103
6 Months’ Follow-Up of the First-in-Man Implantation of a Novel Tricuspid Flow Optimizer 102
Effects of Finerenone on Cardiovascular and Chronic Kidney Diseases: A New Weapon against Cardiorenal Morbidity and Mortality-A Comprehensive Review 100
Systematic review and meta-analysis of randomized and nonrandomized studies on fractional flow reserve-guided revascularization 100
Classification of Aortic Stenosis Patients via ECG-Independent Multi-Site Measurements of Cardiac-Induced Accelerations and Angular Velocities at the Skin Level 96
MANAGEMENT OF IMPLANT FAILURE DURING TRANSCATHETER AORTIC VALVE IMPLANTATION 96
Relation of endothelin-1 to survival in patients with primary pulmonary hypertension 89
The current paradigm of cardiac troponin increase among athletes 88
Practical Guidance for the Use of SGLT2 Inhibitors in Heart Failure 87
Edge-to-edge repair for tricuspid regurgitation: 1-year follow-up and clinical implications from the TR-Interventional Study 84
Different impact of sex on baseline characteristics and major periprocedural outcomes of transcatheter and surgical aortic valve interventions: Results of the multicenter Italian OBSERVANT Registry. 84
Severe heart failure and intracardiac thrombosis: going beyond the appearance for diagnosis and treatments 83
Relazione comparativa tra capacità funzionale e profilo emodinamico in pazienti con scompenso cardiaco cronico biventricolare o scompenso cardiaco destro puro 82
In Stent Neo-Atherosclerosis: Pathophysiology, Clinical Implications, Prevention, and Therapeutic Approaches 81
Cardiac involvement of Gorlin-Goltz syndrome: new light among the shadows of an old congenital disorder 79
Anatomical and Procedural Features Associated with Aortic Root Rupture During Balloon-Expandable Transcatheter Aortic Valve Replacement. 74
EARLY AND MID-TERM OUTCOMES OF TRANSCATHETER AORTIC VALVE IMPLANTATION IN PATIENTS WITH LOGISTIC EUROSCORE LESS THAN 20%: A COMPARATIVE ANALYSIS BETWEEN DIFFERENT RISK STRATA 73
Immediate and 12-Month Outcomes of Ischemic Versus Nonischemic Functional Mitral Regurgitation in Patients Treated With MitraClip (from the 2011 to 2012 Pilot Sentinel Registry of Percutaneous Edge-To-Edge Mitral Valve Repair of the European Society of Cardiology) 73
Traditional and Advanced Echocardiographic Evaluation in Chronic Obstructive Pulmonary Disease: The Forgotten Relation 72
Eosinophilic Myocarditis: From Bench to Bedside 71
The safety of transesophageal echocardiography to guide transcatheter tricuspid valve edge-to-edge repair 70
SAFETY AND EFFECTIVENESS OF THE CATANIA POLYZENE-F COATED STENT IN REAL WORLD CLINICAL PRACTICE: 12-MONTH RESULTS FROM THE ATLANTA 2 REGISTRY 69
Management of patients with patent foramen ovale and cryptogenic stroke: a collaborative, multidisciplinary, position paper: executive summary. 69
UPDATE ON PERCUTANEOUS MITRAL VALVE THERAPY; CLINICAL RESULTS AND REAL LIFE EXPERIENCE 69
Leiomatosi intravenosa con interessamento cardiaco: diagnosi e follow-up ecocardiografico 68
The butterfly effect: Restoring the tricuspid coaptation after clipping the antero-septal commissure 67
FEASIBILITY OF PERCUTANEOUS TRANSCATETHER MITRAL VALVE REPAIR WITH MITRACLIP SYSTEM USING CONSCIOUS SEDATION 67
Evaluation of Cardiac Autonomic Function in Patients Undergoing Thoracoscopic Sympathetic Chain Clamping for Primary Focal Hyperhidrosis 66
Usefulness of Adding Pre-procedural Glycemia to the Mehran Score to Enhance Its Ability to Predict Contrast-induced Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention Development and Validation of a Predictive Model 65
Ipertensione arteriosa polmonare "Primitiva" in soggetti con infezione da HIV: descrizione di tre casi 65
Impact of Chronic Kidney Disease and Platelet Reactivity on Clinical Outcomes Following Percutaneous Coronary Intervention 64
Indirect respiratory monitoring via single-lead wearable ECG: Influence of motion artifacts and devices on respiratory rate estimations 63
Hemodynamic and Myocardial Metabolic Effects of Inodilator Drugs in Severe Heart Failure 63
The Pivotal Role of Invasive Functional Assessment in Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA) 62
Italian PFO closure survey (IPOS): preliminary results 62
EVALUATION OF THE MORPHOLOGY OF THE OVAL FOSSA FOR PLACEMENT OF DEVICES 61
PARAPLEGIA FOLLOWING PERCUTANEOUS BALLOON ANGIOPLASTY OF AORTIC COARCTATION: A CASE REPORT 60
Totale 14.639
Categoria #
all - tutte 205.408
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 205.408


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022509 0 0 14 8 3 9 7 10 6 22 11 419
2022/2023206 7 9 21 17 20 8 9 13 2 0 97 3
2023/20241.763 43 149 62 146 134 590 54 303 56 106 41 79
2024/202512.396 261 150 517 174 108 376 195 62 1.148 1.077 4.067 4.261
2025/202614.141 1.202 474 1.267 2.070 467 866 3.313 1.166 1.061 1.142 725 388
2026/20271.327 259 1.068 0 0 0 0 0 0 0 0 0 0
Totale 30.342